MOLECULAR INSIGHT PHARMACEUTICALS, INC.

Company Information
Address 160 SECOND ST
CAMBRIDGE, MA, 02142-


Information

DUNS: 76298459

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. A kit based PET agent: edotreotide Ga 68 for clinical imaging of somatostatin rec

    Amount: $1,935,675.00

    DESCRIPTION (provided by applicant): A kit based PET agent: edotreotide Ga 68 for clinical imaging of somatostatin receptor expressing tissue. Synthetic peptides targeted to Somatostatin receptors (SS ...

    SBIRPhase II2012Department of Health and Human Services
  2. Early Clinical Testing for Melanin Targeting Radio-therapeutic agent in melanoma

    Amount: $1,296,830.00

    DESCRIPTION (provided by applicant): The ultimate goal of this Fast Track Phase I/II SBIR proposal is to perform the clinical assessment of a novel pharmaceutical agent, ioflubenzamide I-131, to e ...

    SBIRPhase II2010Department of Health and Human Services
  3. Development of a kit based PET molecular imaging agent: edotreotide Ga 68 for so

    Amount: $262,993.00

    DESCRIPTION (provided by applicant): Synthetic peptides targeted to Somatostatin receptors (SSTR) were developed almost 30 years ago by Novartis to inhibit the effects of endogenous growth factors on ...

    SBIRPhase I2010Department of Health and Human Services
  4. Systemic radiotherapy for metastatic melanomas: Innovation of a novel radiopharma

    Amount: $1,634,480.00

    DESCRIPTION (provided by applicant): The ultimate goal of this Fast Track Phase I/II SBIR proposal is to develop the novel pharmaceutical agent 131I-MIP-1145, as a molecular targeting radio-therapeuti ...

    SBIRPhase II2009Department of Health and Human Services
  5. Development of a Molecular Targeting Agent for PSMA to Diagnose Metastatic Prosta

    Amount: $1,617,727.00

    DESCRIPTION (provided by applicant): Abstract There is presently no effective therapy for relapsing, metastatic, androgen-independent prostate cancer and the most effective treatment occurs with early ...

    SBIRPhase II2009Department of Health and Human Services
  6. Early Clinical Testing for Melanin Targeting Radio-therapeutic agent in melanoma

    Amount: $223,985.00

    DESCRIPTION (provided by applicant): The ultimate goal of this Fast Track Phase I/II SBIR proposal is to perform the clinical assessment of a novel pharmaceutical agent, ioflubenzamide I-131, to e ...

    SBIRPhase I2009Department of Health and Human Services
  7. Targeting Tumor Microenvironment with Radiolabeled Inhibitors of Seprase (FAPalph

    Amount: $180,916.00

    DESCRIPTION (provided by applicant): The American Cancer Society estimates that in 2008 there will be more than 1.4 million new cases of cancer in the United States and that it will claim the live ...

    SBIRPhase I2009Department of Health and Human Services
  8. Systemic radiotherapy for metastatic melanomas: Innovation of a novel radiopharma

    Amount: $331,449.00

    DESCRIPTION (provided by applicant): The ultimate goal of this Fast Track Phase I/II SBIR proposal is to develop the novel pharmaceutical agent 131I-MIP-1145, as a molecular targeting radio-therapeuti ...

    SBIRPhase I2008Department of Health and Human Services
  9. Radiolabeled Inhibitors of Carbonic Anhydrase IX

    Amount: $204,351.00

    DESCRIPTION (provided by applicant): The NCI estimates that in 2008 there will be more than 54,000 new cases of renal cell cancer in the United States and that it will claim the lives of more than 13, ...

    SBIRPhase I2008Department of Health and Human Services
  10. Nanodosing: A path to higher sensitivity and lower toxicity pharmaceuticals

    Amount: $981,548.00

    DESCRIPTION (provided by applicant): Current availability of iobenguane I 123 is limited to single doses labeled at regional radiopharmacies with variable formulations and specific activities. The obj ...

    SBIRPhase II2008Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government